Medical News: CMSC: Novel MS Drug May Boost Glatiramer Efficacy - in Meeting Coverage, CMSC from MedPage Today
Links shared publicly online about this topic.
- 238total visits
Medical News: CMSC: Novel MS Drug May Boost Glatiramer Efficacy - in Meeting Coverage, CMSC from MedPage Today
View full resource at medpagetoday.com
Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Drug, Imaging Tests, Copaxone, News, Medical
Most Recently Shared on June 6, 2011 at 6:29 pm By:
CMSC: Novel MS Drug May Boost Glatiramer Efficacy (CME/CE) http://bit.ly/mgy0DC
Medical News: CMSC: Novel MS Drug May Boost Glatiramer Efficacy - in Meeting Coverage, CMSC from MedPage Today
medpagetoday.com — “MONTREAL -- Adding the investigational, oral drug teriflunomide to glatiramer acetate (GA, Copaxone) in patients with relapsing multiple sclerosis substantially decreased the MRI lesion burden, althou” View full resource at medpagetoday.com
Most Recently Shared on August 18, 2011 at 6:43 pm By:
Roger D. Jones, PhD PhD, Doctor, Health Executive, and Health Social Media
CMSC: Novel MS Drug May Boost Glatiramer Efficacy - in Meeting Coverage, CMSC from MedPage Today - http://t.co/Df0q7Bu from @medpagetoday
Medical News: CMSC: Novel MS Drug May Boost Glatiramer Efficacy - in Meeting Coverage, CMSC from MedPage Today
medpagetoday.com — “MONTREAL -- Adding the investigational, oral drug teriflunomide to glatiramer acetate (GA, Copaxone) in patients with relapsing multiple sclerosis substantially decreased the MRI lesion burden, althou” View full resource at medpagetoday.com
Most Recently Shared on June 6, 2011 at 6:57 pm By:
CMSC: Novel MS Drug May Boost Glatiramer Efficacy (CME/CE): MONTREAL (MedPage Today… http://goo.gl/fb/PYJLE
Advertisement
